Dong Kim

Insider Reports History

Location
Princeton, NJ
Signature
/s/ Randy Milby as Attorney-In-Fact for Dong Kim
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Dong Kim:

Form 4 holding Chief Financial Officer

UroGen Pharma Ltd.

Security class
Ordinary Shares
Shares / value
37,753
Estimated value
$493,809
Report date
09 Sep 2024
Price
$13.08
Ownership
Direct
Form 4 holding Chief Financial Officer

UroGen Pharma Ltd.

Security class
Stock Option (right to buy)
Shares / value
20,000
Estimated value
Report date
25 Mar 2022
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount
Form 4 holding Chief Financial Officer

UroGen Pharma Ltd.

Security class
Restricted Stock Units
Shares / value
5,000
Estimated value
Report date
09 Sep 2024
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Insider Reports Filed by Dong Kim

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .